Here's what you missed last week

Last week we aired our 2024 Emergency Briefing. It explains the fundamentals behind one of the most compelling opportunities I've seen in quite a while as Director of Research here at Stansberry. [Stansberry Digest] Here's What You Missed Last Week --------------------------------------------------------------- Last week we aired our 2024 Emergency Briefing. It explains the fundamentals behind one of the most compelling opportunities I've seen in quite a while as Director of Research here at Stansberry. But if you haven't been able to check it out yet, I highly recommend you [go here because there isn't much time left until it disappears for good.]( Now, I'm not sure I recall anything we've sent out to readers having so much immediate urgency... such consequences on the entire financial system... and so much upside potential for readers. To be clear, [the briefing focuses on a historic moment about to occur with cryptocurrencies.]( Chances are you've probably heard about it by now... but there's a lot more to this story right beneath the surface. And it could all lead to what world-renowned crypto expert Eric Wade believes could be [the biggest and perhaps FINAL cryptocurrency bull run]( we'll ever see. I understand that no matter how much potential profit we're discussing... the simple fact that it involves crypto may make you extremely skeptical. But here's what you'll learn from it in a matter of minutes: - Why there's no better time to invest in Bitcoin than now... but why the greatest profit potential actually lies beyond Bitcoin. - Why Eric is issuing the strongest buy recommendation of his entire career today and how to access the names of [the six cryptos his research indicates could each return 1,000% or more]( during the upcoming bull run. Note: NONE of them are Bitcoin. - Why some of Eric's best crypto recommendations could soon start behaving like blue-chip stocks... and why yesterday's most speculative assets could form the core of tomorrow's strongest performing portfolios. - How and why today's headlines are fueling this once in a lifetime opportunity, and why it's so incredibly time sensitive. Just note: If you haven't seen our Emergency Briefing yet... [you must click here before it's pulled offline tomorrow.]( Good investing, Matt Weinschenck Director of Research, Stansberry Research P.S. Don't just take my word for it that Eric's insights and research are worth your time. Plenty of his readers will back up the fact that he's already been able to connect them with tremendous opportunities for profit. Like Darius K. who says: "I'm a very small investor, ($300-$500 per position), and I'm up about $100k... Eric's recommendations have been uncannily accurate..." Stan H. who told us: "My $5,500 investment turned into $320,000." Jim S. wrote to tell Eric: "I turned $3,000 into $195,000 on a single recommendation from you." And Elizabeth C. reported that thanks to Eric's work: "My portfolio increased by more than $1 million in 12 months." [Go here now to find out how the latest, and perhaps greatest opportunity he's uncovered could do the same for you.]( --------------------------------------------------------------- Standard Disclaimer: The investment results described in these testimonials may not be typical. Investing in securities carries a high degree of risk; you may lose some or all of the investment. Published by Stansberry Research. You have received this e-mail as part of your subscription to Stansberry Digest . If you no longer wish to receive special offers from Stansberry Digest, [click here](. You’re receiving this e-mail at {EMAIL}. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized financial advice. © 2024 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 [stansberryresearch.com](.